Helen Boucher still feels frustrated when thinking about the patient who had congestive heart failure.
The middle-aged man needed a heart transplant, but ran into a serious obstacle. He had undergone knee replacement surgery and...
Solutions To The AMR ‘Silent Pandemic’ Need More Than Just Lip Service
Antibiotics Innovators Bemoan Lack Of Incentives And Rewards In Face Of Ever-Growing AMR Threat
With new antibiotics a rare commodity, persistently inadequate reimbursement for innovations and worthy but often piecemeal pilots, antimicrobial resistance has quietly risen to become a factor in well over a million deaths annually. Now that COVID-19 is not the all-encompassing threat to health it was until fairly recently, AMR is once again moving towards the center of attention. But properly funded actions and mindset changes are needed.
